Cargando…

New Insights in PRRT: Lessons From 2021

Peptide receptor radionuclide therapy (PRRT) using radiolabeled somatostatin analogs has been used for over two decades for the treatment of well-differentiated neuroendocrine tumors (NETs), and the publication of the NETTER-1 trials has further strengthened its clinical use. However, many aspects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Puliani, Giulia, Chiefari, Alfonsina, Mormando, Marilda, Bianchini, Marta, Lauretta, Rosa, Appetecchia, Marialuisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016202/
https://www.ncbi.nlm.nih.gov/pubmed/35450421
http://dx.doi.org/10.3389/fendo.2022.861434